rs794728905
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PP2
The NM_000335.5(SCN5A):c.86_87delCAinsTG(p.Ala29Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. A29A) has been classified as Benign.
Frequency
Genomes: not found (cov: 29)
Consequence
SCN5A
NM_000335.5 missense
NM_000335.5 missense
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.46
Genes affected
SCN5A (HGNC:10593): (sodium voltage-gated channel alpha subunit 5) The protein encoded by this gene is an integral membrane protein and tetrodotoxin-resistant voltage-gated sodium channel subunit. This protein is found primarily in cardiac muscle and is responsible for the initial upstroke of the action potential in an electrocardiogram. Defects in this gene have been associated with long QT syndrome type 3 (LQT3), atrial fibrillation, cardiomyopathy, and Brugada syndrome 1, all autosomal dominant cardiac diseases. Alternative splicing results in several transcript variants encoding different isoforms. [provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 5 ACMG points.
PM1
In a topological_domain Cytoplasmic (size 130) in uniprot entity SCN5A_HUMAN there are 19 pathogenic changes around while only 2 benign (90%) in NM_000335.5
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), SCN5A. . Gene score misZ 2.7504 (greater than the threshold 3.09). Trascript score misZ 4.8279 (greater than threshold 3.09). GenCC has associacion of gene with progressive familial heart block, type 1A, Brugada syndrome, familial sick sinus syndrome, short QT syndrome, paroxysmal familial ventricular fibrillation, progressive familial heart block, long QT syndrome 3, familial atrial fibrillation, catecholaminergic polymorphic ventricular tachycardia, dilated cardiomyopathy, dilated cardiomyopathy 1E, arrhythmogenic right ventricular cardiomyopathy, Brugada syndrome 1, atrial standstill, familial isolated dilated cardiomyopathy, familial long QT syndrome, sick sinus syndrome 1.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN5A | NM_001099404.2 | c.86_87delCAinsTG | p.Ala29Val | missense_variant | ENST00000413689.6 | NP_001092874.1 | ||
SCN5A | NM_000335.5 | c.86_87delCAinsTG | p.Ala29Val | missense_variant | ENST00000423572.7 | NP_000326.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN5A | ENST00000413689.6 | c.86_87delCAinsTG | p.Ala29Val | missense_variant | 5 | NM_001099404.2 | ENSP00000410257.1 | |||
SCN5A | ENST00000423572.7 | c.86_87delCAinsTG | p.Ala29Val | missense_variant | 1 | NM_000335.5 | ENSP00000398266.2 |
Frequencies
GnomAD3 genomes Cov.: 29
GnomAD3 genomes
Cov.:
29
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 29
GnomAD4 genome
Cov.:
29
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 20, 2024 | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 29 of the SCN5A protein (p.Ala29Val). This variant is present in population databases (rs794728905, gnomAD 0.008%). This missense change has been observed in individual(s) with SCN5A-related conditions (PMID: 23098067, 28611029, 33221895). ClinVar contains an entry for this variant (Variation ID: 242209). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Feb 23, 2022 | A nucleotide substitution (c.86C>T) which results in the same amino acid substitution, A29V, has been reported in a patient with presyncope and a QTc of 490ms, who also harbored a pathogenic variant in the KCNQ1 gene (Stattin et al., 2012); In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23098067, 33221895) - |
SCN5A-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | May 08, 2023 | The SCN5A c.86_87delinsTG variant is predicted to result in an in-frame deletion and insertion. This variant was reported in an individual with Brugada syndrome (Table S5, Ciconte et al. 2020. PubMed ID: 33221895). Of note, this variant may be reported in a large population database as two separate entries as c.87A>G (https://gnomad.broadinstitute.org/variant/3-38674712-T-C) and c.86C>T (https://gnomad.broadinstitute.org/variant/3-38674713-G-A). A similar variant resulting in the same amino acid substitution, c.86C>T (p.Ala29Val), has been reported in individuals with long QT syndrome, dilated cardiomyopathy, or sudden death (Stattin et al. 2012. PubMed ID: 23098067; Table S2, Methner et al. 2016. PubMed ID: 27435932; Table S2, Haskell et al. 2017. PubMed ID: 28611029). At this time, the clinical significance of the c.86_87delinsTG (p.Ala29Val) variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
SUDDEN INFANT DEATH SYNDROME;C1832680:Dilated cardiomyopathy 1E;C1837845:Sick sinus syndrome 1;C1859062:Long QT syndrome 3;C1879286:Progressive familial heart block, type 1A;C2751898:Ventricular fibrillation, paroxysmal familial, type 1;C3151464:Atrial fibrillation, familial, 10;C4551804:Brugada syndrome 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Nov 10, 2021 | - - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 03, 2022 | The c.86_87delCAinsTG variant (also known as p.A29V), located in coding exon 1 of the SCN5A gene, results from an in-frame deletion of CA and insertion of TG at nucleotide positions 86 to 87. This results in the substitution of the alanine residue for a valine residue at codon 29, an amino acid with similar properties. This alteration has been reported in a Brugada syndrome cohort; however, clinical details were limited (Ciconte G et al. Eur Heart J, 2021 03;42:1082-1090). Another alteration at the same codon, p.A29V (c.86C>T), has been described in individuals with a prolonged QT interval and a sudden unexplained infant death cohort (Stattin EL et al. BMC Cardiovasc Disord, 2012 Oct;12:95; Methner DN et al. Genome Res, 2016 09;26:1170-7; Haskell GT et al. Circ Cardiovasc Genet, 2017 Jun;10:[ePub ahead of print]). Based on data from gnomAD, the TG allele has an overall frequency of 0.008% (22/280148) total alleles studied. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be inconclusive by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Cardiac arrhythmia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Oct 11, 2022 | This missense variant replaces alanine with valine at codon 29 of the SCN5A protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). A functional study has shown this variant reduces the sodium inward current (Murano et. al, 2019). This variant has been reported in an individual affected with Brugada syndrome (Murano et. al, 2019). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at